この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1994/5/231 分で読めます
Astra USA, Inc., et al.; Withdrawal of Approval of 62 Abbreviated New Drug Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of 62 abbreviated new drug applications (ANDA's). The holders of the ANDA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. EFFECTIVE DATE: June 22, 1994. FOR FURTHER INFORMATION CONTACT: Lola E. Batson, Center for Drug Evaluation and Research (HFD-360), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-594-1038.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →